Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Cue Health
(NASDAQ:HLTH)
Intraday
$0.1371
-0.0089
[-6.10%]
After-Hours
$0.1445
0.0074
[5.40%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.1371
-0.0089
[-6.10%]
At close: Apr 30
$0.1445
0.0074
[5.40%]
After Hours: 9:29AM EDT
Get Report
Watch
Q1 2024 Earnings in 13 days from now on Mon May 13th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Cue Health Stock (NASDAQ:HLTH)
Cue Health Stock (NASDAQ: HLTH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 19, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Apr 19, 2024, 8:08AM
Monday, April 15, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Apr 15, 2024, 4:31PM
Tuesday, April 09, 2024
Cue Health Disclosed It Has Been Undertaking Comprehensive Review Of Strategic Alternative; Strategic Review Process To Evaluate Options Including Potential Sale
Benzinga Newsdesk
-
Apr 9, 2024, 9:08AM
Monday, April 08, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Apr 8, 2024, 4:31PM
Wednesday, March 20, 2024
Cue Health Reveals Strategic Actions; Names Clint Sever As CEO; Seeks To Refine And Strengthen Its Overarching Strategy And Cost Structure
Benzinga Newsdesk
-
Mar 20, 2024, 5:23PM
Friday, March 15, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Mar 15, 2024, 5:33PM
Thursday, March 14, 2024
Cue Health shares are trading lower after the company reported Q4 financial results and issued Q1 revenue guidance below estimates. Also, BTIG downgraded the stock from Buy to Neutral.
Benzinga Newsdesk
-
Mar 14, 2024, 1:28PM
BTIG Downgrades Cue Health to Neutral
Benzinga Newsdesk
-
Mar 14, 2024, 8:26AM
Wednesday, March 13, 2024
Cue Health Sees Q1 2024 Revenue $9M-$11M Vs $28.921M Est.
Benzinga Newsdesk
-
Mar 13, 2024, 4:27PM
Cue Health: Q4 Earnings Insights
Benzinga Insights
-
Mar 13, 2024, 4:10PM
Cue Health Q4 2023 Adj EPS $(0.32) Beats $(0.44) Estimate, Sales $18.798M Beat $17.681M Estimate
Benzinga Newsdesk
-
Mar 13, 2024, 4:05PM
Earnings Scheduled For March 13, 2024
Benzinga Insights
-
Mar 13, 2024, 6:15AM
Tuesday, March 12, 2024
Cue Health's Earnings Outlook
Benzinga Insights
-
Mar 12, 2024, 12:01PM
Friday, March 01, 2024
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Mar 1, 2024, 1:19PM
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 1, 2024, 8:31AM
Thursday, February 29, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Feb 29, 2024, 4:31PM
Cue Health Has Received A Decision To Grant European Patent Number EP3191849 Titled "Systems And Methods For Detection And Quantification Of Analytes"
Benzinga Newsdesk
-
Feb 29, 2024, 3:59PM
Thursday, January 25, 2024
Hlth Cue Health Says Estimates Will Record Aggregate Restructuring Charge Related To One-time Termination Benefits In Range Of About $3.2M To $4.0M
Benzinga Newsdesk
-
Jan 25, 2024, 4:44PM
Hlth Cue Health Says Plan Will Include A Reduction In Company's Employee Base By 151 Employees' On Jan. 25 Implemented A New Cost Reduction Plan; Plan Constitutes A Reduction Of ~24% In Global Workforce
Benzinga Newsdesk
-
Jan 25, 2024, 4:44PM
Tuesday, January 23, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Jan 23, 2024, 4:31PM
Friday, January 05, 2024
Cue Health Says Letter Shows FDA Determined Further Review Of Co's EUA Request Is Not Priority, Therefore Declines To Issue EUA For Product At This Time; Expects Payments Relating To The CRP To Be Completed By The End Of Q3 Of 2024
Benzinga Newsdesk
-
Jan 5, 2024, 4:19PM
Cue Health Got Response Letter From FDA On Dec 28 On EUA Submission For Flu A/B + Covid-19 Molecular Test For Over The Counter And Point Of Care Use
Benzinga Newsdesk
-
Jan 5, 2024, 4:18PM
Cue Health Inc On Jan. 4, 2024, Implemented A New Cost Reduction Plan; To Include A Reduction In Employee Base By 94 Employees, Which Constitutes A Reduction Of About 13% In Co's Global Workforce
Benzinga Newsdesk
-
Jan 5, 2024, 4:13PM
Tuesday, January 02, 2024
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Jan 2, 2024, 1:35PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jan 2, 2024, 12:31PM
Dow Down 100 Points; US Manufacturing PMI Falls In December
Avi Kapoor
-
Jan 2, 2024, 9:53AM
Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 2, 2024, 8:07AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jan 2, 2024, 8:05AM
Monday, January 01, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Jan 1, 2024, 4:30PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jan 1, 2024, 12:30PM
Friday, December 29, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Dec 29, 2023, 4:31PM
Monday, December 11, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Dec 11, 2023, 4:31PM
Friday, November 10, 2023
Goldman Sachs Maintains Neutral on Cue Health, Lowers Price Target to $0.5
Benzinga Newsdesk
-
Nov 10, 2023, 10:58AM
Wednesday, November 08, 2023
Cue Health Sees Q4 Revenue $16M-$18M Vs $27.45M Est.
Benzinga Newsdesk
-
Nov 8, 2023, 6:06PM
Cue Health: Q3 Earnings Insights
Benzinga Insights
-
Nov 8, 2023, 4:45PM
Cue Health Q3 2023 Adj EPS $(0.42) Beats $(0.45) Estimate, Sales $17.48M Beat $16.66M Estimate
Benzinga Newsdesk
-
Nov 8, 2023, 4:43PM
Earnings Scheduled For November 8, 2023
Benzinga Insights
-
Nov 8, 2023, 4:21AM
Wednesday, October 25, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Oct 25, 2023, 9:05AM
Thursday, October 19, 2023
Independent Clinical Study Confirms Cue Health's COVID-19 Test Is As Accurate As A Lab Test
Rachael Green
-
Sponsored
Wednesday, October 18, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Oct 18, 2023, 5:31PM
Monday, October 16, 2023
Cue Health 13D Filing Shows Oakmont Corp Reports 6.3% Stake In Co As Of October 6, 2023
Benzinga Newsdesk
-
Oct 16, 2023, 3:30PM
Wednesday, October 04, 2023
Peer-Reviewed Independent Study Published In Microbiology Spectrum Finds Cue Health's Molecular COVID-19 Test Is As Accurate As A Lab-Based PCR Test
Benzinga Newsdesk
-
Oct 4, 2023, 9:21AM
Thursday, September 21, 2023
Cue Health Adopts Limited-Duration Shareholder Rights Plan In Response To Rapid Accumulation Of Shares By A Third Party
Benzinga Newsdesk
-
Sep 21, 2023, 4:24PM
Tuesday, September 05, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Sep 5, 2023, 5:31PM
Thursday, August 31, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Aug 31, 2023, 1:31PM
Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Aug 31, 2023, 12:50PM
Tarsadia Investments Sends Letter To Board Of Cue Health, Inc.; Calls On Board To Take Immediate Action To Prevent Further Destruction Of Stockholder Value
Happy Mohamed
-
Aug 31, 2023, 10:05AM
Thursday, August 24, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Aug 24, 2023, 5:32PM
Thursday, August 17, 2023
This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test
Rachael Green
-
Sponsored
Wednesday, August 09, 2023
Cue Health Expects Q3 Revenues Of $11M-$13M, Consensus $16.43M
Benzinga Newsdesk
-
Aug 9, 2023, 5:49PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch